Healthcare provider profile · identity verified

Paul Edward Dillon, M.D.

Family Practice · SIMPSONVILLE, SC · NPI 1184662033

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	125
Metformin Hcl Er	Metformin Hcl	326	82
Lisinopril	Lisinopril	302	83
Amlodipine Besylate	Amlodipine Besylate	282	76
Omeprazole	Omeprazole	221	65
Levothyroxine Sodium	Levothyroxine Sodium	214	59
Rosuvastatin Calcium	Rosuvastatin Calcium	166	56
Glipizide Er	Glipizide	164	41
Clonazepam	Clonazepam	162	27
Escitalopram Oxalate	Escitalopram Oxalate	154	40
Simvastatin	Simvastatin	150	41
Metoprolol Succinate	Metoprolol Succinate	147	46
Hydrochlorothiazide	Hydrochlorothiazide	126	36
Pioglitazone Hcl	Pioglitazone Hcl	125	32
Gabapentin	Gabapentin	123	35
Sertraline Hcl	Sertraline Hcl	120	30
Tamsulosin Hcl	Tamsulosin Hcl	118	41
Losartan Potassium	Losartan Potassium	117	34
Trazodone Hcl	Trazodone Hcl	109	27
Famotidine	Famotidine	102	32
Allopurinol	Allopurinol	100	23
Duloxetine Hcl	Duloxetine Hcl	99	28
Pravastatin Sodium	Pravastatin Sodium	99	26
Methylprednisolone	Methylprednisolone	97	79
Lorazepam	Lorazepam	94	21
Montelukast Sodium	Montelukast Sodium	91	22
Fluticasone Propionate	Fluticasone Propionate	84	30
Furosemide	Furosemide	82	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	81	25
Tramadol Hcl	Tramadol Hcl	81	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	20
Irbesartan	Irbesartan	78	20
Pantoprazole Sodium	Pantoprazole Sodium	77	23
Atenolol	Atenolol	74	19
Zolpidem Tartrate	Zolpidem Tartrate	74	13
Glimepiride	Glimepiride	70	18
Lovastatin	Lovastatin	70	19
Tizanidine Hcl	Tizanidine Hcl	70	26
Eliquis	Apixaban	69	17
Metformin Hcl	Metformin Hcl	68	22
Potassium Chloride	Potassium Chloride	65	19
Pregabalin	Pregabalin	64	18
Albuterol Sulfate Hfa	Albuterol Sulfate	59	24
Alprazolam	Alprazolam	59	suppressed
Celecoxib	Celecoxib	57	15
Valacyclovir	Valacyclovir Hcl	55	14
Alendronate Sodium	Alendronate Sodium	54	14
Esomeprazole Magnesium	Esomeprazole Magnesium	54	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	15
Carvedilol	Carvedilol	50	18
Diclofenac Sodium	Diclofenac Sodium	50	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	16
Fluoxetine Hcl	Fluoxetine Hcl	48	13
Valsartan	Valsartan	48	11
Diazepam	Diazepam	47	suppressed
Doxepin Hcl	Doxepin Hcl	46	suppressed
Promethazine Hcl	Promethazine Hcl	46	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	46	12
Amoxicillin	Amoxicillin	44	38
Bupropion Xl	Bupropion Hcl	44	15
Memantine Hcl	Memantine Hcl	44	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Mirtazapine	Mirtazapine	42	11
Azithromycin	Azithromycin	41	35
Finasteride	Finasteride	41	11
Jardiance	Empagliflozin	41	13
Meloxicam	Meloxicam	41	15
Citalopram Hbr	Citalopram Hydrobromide	40	12
Ezetimibe	Ezetimibe	40	14
Ozempic	Semaglutide	40	suppressed
Prednisone	Prednisone	38	24
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	36	suppressed
Torsemide	Torsemide	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Ramipril	Ramipril	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Cefuroxime	Cefuroxime Axetil	30	28
Xarelto	Rivaroxaban	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	11
Topiramate	Topiramate	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Mounjaro	Tirzepatide	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	23
Fenofibrate	Fenofibrate	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	23
Lansoprazole	Lansoprazole	23	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	19
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Cefadroxil	Cefadroxil	18	17
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Linzess	Linaclotide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Temazepam	Temazepam	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Primidone	Primidone	11	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error